MedPath

Clinical observation of Huanglian Jiedu Decoction in the treatment of Metabolic Syndrome

Phase 1
Recruiting
Conditions
Metabolic Syndrome
Registration Number
ITMCTR2100004436
Lead Sponsor
Changzhou Hospital of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1.It meets the diagnostic criteria of metabolic syndrome;
2.Aged 18 to 70 years;
3.Signed the Informed Consent;
4.Those who can recheck regularly and cooperate with the treatment.

Exclusion Criteria

1. Those who are suffering from acute diabetic complications within 1 month;
2. Complicated with acute infection;
3. Complicated with severe heart, liver and kidney diseases;
4. Pregnant or lactating women;
5. Patients suffering from acute coronary syndrome or acute stroke;
6. Those who have taken drugs similar to the study drugs or drugs with antagonistic effects in the past 2 months;
7. Those who is currently participating in other drug clinical research projects.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ALT;AST;BUN;PLT;triglyceride;high density lipoprotein cholesterol;GRA;low density lipoprotein cholesterin;IL-6;HbA1C;c reactive protein;TNF-a;Cr;LYM;HGB;WBC;postprandial blood sugar;insulin;UA;total cholesterol;free fatty acid;fasting blood-glucose;RBC;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath